Session 4: Late-breaking and Hot Topics in Endovascular Therapy

Session 4: Late-breaking and Hot Topics in Endovascular Therapy

On-Demand Webcast

 

Thursday, January 23, 2020

11:55 - 12:43 PM

Presentations

Understanding the Current FDA Position regarding Paclitaxel
Ryan Randall

Death Rates in the PTX PCB and PTX DES Studies at 5 Years
Gunnar Tepe

Paclitaxel Safety Update from Real World Data
Eric Secemsky

Eluvia DES: 2-year Results in High Risk Patients from the Only Polymer Based Paclitaxel Technology
William Gray

IN.PACT Global Study 4-Year Outcomes
Gunnar Tepe

Lutonix Syntactyx Safety Analysis
Constantino Peña

Stellarex DCB in the Complex Patient: Analysis of the SAVER Registry
Gunnar Tepe